- Home
- BNT vs PODD Comparison
BNT vs PODD Comparison
Compare BNT & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNT | PODD |
|---|---|---|
| Founded | 2020 | 2000 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 10.3B |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | BNT | PODD |
|---|---|---|
| Price | $42.23 | $143.05 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 21 |
| Target Price | N/A | ★ $341.48 |
| AVG Volume (30 Days) | 9.8K | ★ 1.7M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.65% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.67 |
| Revenue | N/A | ★ $2,708,100,000.00 |
| Revenue This Year | N/A | $24.55 |
| Revenue Next Year | N/A | $19.18 |
| P/E Ratio | ★ $19.14 | $54.46 |
| Revenue Growth | N/A | ★ 30.73 |
| 52 Week Low | $40.06 | $126.40 |
| 52 Week High | $74.16 | $354.88 |
Technical Indicators
Market Signals| Indicator | BNT | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 39.74 | 43.52 |
| Support Level | $41.95 | $139.23 |
| Resistance Level | $46.81 | $170.20 |
| Average True Range (ATR) | 0.70 | 5.61 |
| MACD | -0.30 | 0.06 |
| Stochastic Oscillator | 13.87 | 57.60 |
Price Performance
Historical ComparisonAbout BNT Brookfield Wealth Solutions Ltd.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. The Company's reporting segments are Annuities, P&C, Life Insurance and Corporate and Other. Majority revenue is generated from Annuities segment followed by P&C.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.